{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T00:40:20Z","timestamp":1738975220627,"version":"3.37.0"},"reference-count":58,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1097\/hjh.0b013e3282efeecb","type":"journal-article","created":{"date-parts":[[2009,3,4]],"date-time":"2009-03-04T00:06:23Z","timestamp":1236125183000},"page":"2486-2496","source":"Crossref","is-referenced-by-count":23,"title":["Long-term nebivolol administration reduces renal fibrosis and prevents endothelial dysfunction in rats with hypertension induced by renal mass reduction"],"prefix":"10.1097","volume":"25","author":[{"given":"Mar\u00eda J","family":"Pires","sequence":"first","affiliation":[]},{"given":"Ana B","family":"Rodr\u00edguez-Pe\u00f1a","sequence":"additional","affiliation":[]},{"given":"Miguel","family":"Ar\u00e9valo","sequence":"additional","affiliation":[]},{"given":"Bego\u00f1a","family":"Cenador","sequence":"additional","affiliation":[]},{"given":"Stefano","family":"Evangelista","sequence":"additional","affiliation":[]},{"given":"Alejandro","family":"Esteller","sequence":"additional","affiliation":[]},{"given":"\u00c1ngel","family":"S\u00e1nchez-Rodr\u00edguez","sequence":"additional","affiliation":[]},{"given":"Aura","family":"Cola\u00e7o","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 M","family":"L\u00f3pez-Novoa","sequence":"additional","affiliation":[]}],"member":"276","reference":[{"key":"R1-18-20210208","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/ki.1997.2","article-title":"Understanding the nature of renal disease progression","volume":"51","author":"Remuzzi","year":"1997","journal-title":"Kidney Int"},{"key":"R2-18-20210208","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1172\/JCI112013","article-title":"Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass","volume":"76","author":"Anderson","year":"1985","journal-title":"J Clin Invest"},{"key":"R3-18-20210208","first-page":"F324","article-title":"Nephron adaptation to renal injury or ablation","volume":"249","author":"Brenner","year":"1985","journal-title":"Am J Physiol"},{"key":"R4-18-20210208","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.semnephrol.2004.04.010","article-title":"L-arginine as a therapeutic tool in kidney disease","volume":"24","author":"Klahr","year":"2004","journal-title":"Semin Nephrol"},{"key":"R5-18-20210208","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0272-6386(99)70229-5","article-title":"Renoprotection by nitric oxide donor and lisinopril in the remnant kidney model","volume":"33","author":"Benigni","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"R6-18-20210208","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0014-2999(89)90047-2","article-title":"Nebivolol is devoid of sympathomimetic activity","volume":"159","author":"Janssens","year":"1989","journal-title":"Eur J Pharmacol"},{"key":"R7-18-20210208","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1038\/sj.bjp.0704188","article-title":"Nebivolol, bucindolol, metoprolol and carvedilol are devoid of intrinsic sympathomimetic activity in human myocardium","volume":"133","author":"Brixius","year":"2001","journal-title":"Br J Pharmacol"},{"key":"R8-18-20210208","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1097\/00005344-199106000-00016","article-title":"Nebivolol induces endothelium-dependent relaxations of canine coronary arteries","volume":"17","author":"Gao","year":"1991","journal-title":"J Cardiovasc Pharmacol"},{"key":"R9-18-20210208","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0014-2999(02)02875-3","article-title":"\u03b2-Adrenoceptor selectivity of nebivolol and bisoprolol. A comparison of [3H]CGP 12.177 and [125I]iodocyanopindolol binding studies","volume":"460","author":"Bundkirchen","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"R10-18-20210208","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/08038020410016557","article-title":"Experimental evidence of nitric oxide-dependent vasodilatory activity of nebivolol, a third generation \u03b2-blocker","volume":"13","author":"Ignarro","year":"2004","journal-title":"Blood Press"},{"key":"R11-18-20210208","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/00005344-200009000-00006","article-title":"Nebivolol induces NO-mediated relaxations of rat small resistance but not of large elastic arteries","volume":"36","author":"Altwegg","year":"2000","journal-title":"J Cardiovasc Pharmacol"},{"key":"R12-18-20210208","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/00005344-200112000-00014","article-title":"Effects of nebivolol on human platelet aggregation","volume":"38","author":"Falciani","year":"2001","journal-title":"J Cardiovasc Pharmacol"},{"key":"R13-18-20210208","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2125.1994.tb04342.x","article-title":"Nitric oxide mediated venodilator effect of nebivolol","volume":"38","author":"Bowman","year":"1994","journal-title":"Br J Clin Pharmacol"},{"key":"R14-18-20210208","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0022-3565(25)10549-1","article-title":"Nebivolol vasodilates human forearm vasculature: evidence for an L-arginine\/NO-dependent mechanism","volume":"274","author":"Cockroft","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"R15-18-20210208","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1161\/hc3001.094207","article-title":"Nebivolol reverses endothelial dysfunction in essential hypertension: a randomised, double-blind, cross-over study","volume":"104","author":"Tzemos","year":"2001","journal-title":"Circulation"},{"key":"R16-18-20210208","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/01.hjh.0000160216.86597.ff","article-title":"Nebivolol decreases oxidative stress in essential hypertensive patients and increases nitric oxide by reducing its oxidative inactivation","volume":"23","author":"Fratta Pasini","year":"2005","journal-title":"J Hypertens"},{"key":"R17-18-20210208","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0014-2999(90)90087-M","article-title":"The L-enantiomer of nebivolol potentiates the blood pressure lowering effect of the D-enantiomer","volume":"181","author":"Xhonneux","year":"1990","journal-title":"Eur J Pharmacol"},{"key":"R18-18-20210208","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/00005344-200309000-00005","article-title":"Long-term treatment with nebivolol improves arterial reactivity and reduces ventricular hypertrophy in spontaneously hypertensive rats","volume":"42","author":"Guerrero","year":"2003","journal-title":"J Cardiovasc Pharmacol"},{"key":"R19-18-20210208","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ejphar.2005.02.003","article-title":"Involvement of nitric oxide in both central and peripheral haemodynamic effect of D\/L-nebivolol and its enantiomers in rats","volume":"511","author":"Sacco","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"R20-18-20210208","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1161\/01.CIR.0000066912.58385.DE","article-title":"Third-generation beta-blockers stimulate nitric oxide release from endothelial cells through ATP efflux: a novel mechanism for antihypertensive action","volume":"107","author":"Kalinowski","year":"2003","journal-title":"Circulation"},{"key":"R21-18-20210208","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejphar.2004.11.043","article-title":"The cellular mechanisms involved in the vasodilator effect of nebivolol on the renal artery","volume":"508","author":"Georgescu","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"R22-18-20210208","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1161\/01.HYP.33.1.467","article-title":"Effects of vasodilatory beta-adrenoceptor antagonists on endothelium-derived nitric oxide release in rat kidney","volume":"33","author":"Kakoki","year":"1999","journal-title":"Hypertension"},{"issue":"Suppl 1","key":"R23-18-20210208","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/ndt\/16.suppl_1.34","article-title":"Up-regulation of endoglin, a TGF-beta-binding protein, in rats with experimental renal fibrosis induced by renal mass reduction","volume":"16","author":"Rodriguez-Pena","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"R24-18-20210208","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0022-3565(25)12464-6","article-title":"Platelet activating factor antagonist treatment protects against postischemic acute renal failure in rats","volume":"253","author":"L\u00f3pez-Farr\u00e9","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"R25-18-20210208","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1016\/j.fct.2006.07.012","article-title":"Protective effect of quercetin on experimental chronic cadmium nephrotoxicity in rats is based on its antioxidant properties","volume":"44","author":"Morales","year":"2006","journal-title":"Food Chem Toxicol"},{"key":"R26-18-20210208","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000020503","article-title":"Beneficial effect of the long-term treatment with the combination of an ACE-inhibitor and calcium channel blocker on renal injury in rats with 5\/6 nephrectomy","volume":"6","author":"Flores","year":"1998","journal-title":"Exp Nephrol"},{"key":"R27-18-20210208","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1172\/JCI0215493","article-title":"In vivo bradykinin B2 receptor activation reduces renal fibrosis","volume":"110","author":"Schanstra","year":"2002","journal-title":"J Clin Invest"},{"key":"R28-18-20210208","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1161\/01.HYP.0000037429.73954.27","article-title":"Endoglin upregulation during experimental renal interstitial fibrosis in mice","volume":"40","author":"Rodriguez-Pena","year":"2002","journal-title":"Hypertension"},{"key":"R29-18-20210208","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1096\/fj.03-0197fje","article-title":"Endoglin regulates nitric oxide-dependent vasodilatation","volume":"18","author":"Jerkic","year":"2004","journal-title":"FASEB J"},{"key":"R30-18-20210208","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/CIRCULATIONAHA.105.611111","article-title":"Mice deficient in telomerase activity develop hypertension because of an excess of endothelin production","volume":"114","author":"Perez-Rivero","year":"2006","journal-title":"Circulation"},{"key":"R31-18-20210208","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/08038020410016548","article-title":"Clinical pharmacodynamics of nebivolol: new evidence of nitric oxide-mediated vasodilating activity and peculiar haemodynamic properties in hypertensive patients","volume":"1","author":"Zanchetti","year":"2004","journal-title":"Blood Press Suppl"},{"key":"R32-18-20210208","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1100\/tsw.2002.814","article-title":"Nebivolol ameliorates nitric oxide deficient hypertension","volume":"2","author":"Fortepiani","year":"2002","journal-title":"Sci World J"},{"key":"R33-18-20210208","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/01.hjh.0000198035.16634.c1","article-title":"Cardiovascular effects of nebivolol in spontaneously hypertensive rats persist after treatment withdrawal","volume":"24","author":"Guerrero","year":"2006","journal-title":"J Hypertens"},{"key":"R34-18-20210208","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000071736","article-title":"Role of TGF-beta in the progression of renal fibrosis","volume":"139","author":"Tamaki","year":"2003","journal-title":"Contrib Nephrol"},{"key":"R35-18-20210208","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/00004872-200304000-00021","article-title":"Angiotensin-converting enzyme inhibition but not beta-adrenergic blockade limits transforming growth factor-beta overexpression in acute normotensive antithy1 glomerulonephritis","volume":"21","author":"Peters","year":"2003","journal-title":"J Hypertens"},{"key":"R36-18-20210208","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/ki.1997.317","article-title":"Renal and systemic nitric oxide synthesis in rats with renal mass reduction","volume":"52","author":"Aiello","year":"1997","journal-title":"Kidney Int"},{"key":"R37-18-20210208","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1038\/ki.1995.214","article-title":"Oral administration of L-arginine and captopril in rats prevents chronic renal failure by nitric oxide production","volume":"47","author":"Ashab","year":"1995","journal-title":"Kidney Int"},{"key":"R38-18-20210208","first-page":"F794","article-title":"Nitric oxide production is low in end-stage renal disease patients on peritoneal dialysis","volume":"276","author":"Schmidt","year":"1999","journal-title":"Am J Physiol"},{"key":"R39-18-20210208","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1046\/j.1523-1755.2000.00281.x","article-title":"Total nitric oxide production is low in patients with chronic renal disease","volume":"58","author":"Schmidt","year":"2000","journal-title":"Kidney Int"},{"key":"R40-18-20210208","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1523-1755.2005.00380.x","article-title":"Stimulation of soluble guanylate cyclase slows progression in antithy1-induced chronic glomerulosclerosis","volume":"68","author":"Wang","year":"2005","journal-title":"Kidney Int"},{"key":"R41-18-20210208","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1097\/01.ASN.0000086476.48686.7D","article-title":"Protection of Wistar Furth rats from chronic renal disease is associated with maintained renal nitric oxide synthase","volume":"14","author":"Erdely","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"R42-18-20210208","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1161\/01.HYP.0000099240.89890.94","article-title":"Renal effects of omapatrilat and captopril in salt-loaded, nitric oxide-deficient rats","volume":"42","author":"Ying","year":"2003","journal-title":"Hypertension"},{"key":"R43-18-20210208","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1161\/01.HYP.32.6.958","article-title":"Chronic nitric oxide inhibition model six years on","volume":"32","author":"Zatz","year":"1998","journal-title":"Hypertension"},{"key":"R44-18-20210208","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s004670050591","article-title":"Vitamin E suppresses oxidative stress and glomerulosclerosis in rat remnant kidney","volume":"13","author":"Hahn","year":"1999","journal-title":"Pediatr Nephrol"},{"key":"R45-18-20210208","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1681\/ASN.V9112089","article-title":"Glomerulosclerosis in the remnant kidney rat is modulated by dietary alpha-tocopherol","volume":"9","author":"Hahn","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"R46-18-20210208","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1046\/j.1523-1755.2002.00166.x","article-title":"Endothelial dysfunction and hypertension in 5\/6 nephrectomized rats are mediated by vascular superoxide","volume":"61","author":"Hasdan","year":"2002","journal-title":"Kidney Int"},{"key":"R47-18-20210208","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1097\/01.ASN.0000117774.83396.E9","article-title":"Antioxidant intervention blunts renal injury in experimental renovascular disease","volume":"15","author":"Chade","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R48-18-20210208","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/00005344-200401000-00022","article-title":"Antioxidant activity of nebivolol in the rat aorta","volume":"43","author":"De Groot","year":"2004","journal-title":"J Cardiovasc Pharmacol"},{"key":"R49-18-20210208","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1161\/01.ATV.0000065234.70518.26","article-title":"Nebivolol prevents vascular NOS III uncoupling in experimental hyperlipidemia and inhibits NADPH oxidase activity in inflammatory cells","volume":"23","author":"Mollnau","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R50-18-20210208","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000078404","article-title":"Oxidative stress status in kidney tissue after losartan and atenolol treatment in experimental renal failure","volume":"97","author":"Pechter","year":"2004","journal-title":"Nephron Exp Nephrol"},{"key":"R51-18-20210208","doi-asserted-by":"crossref","first-page":"24441","DOI":"10.1074\/jbc.274.35.24441","article-title":"Isoprostanes: Formation, analysis and use as indices of lipid peroxidation in vivo","volume":"274","author":"Lawson","year":"1999","journal-title":"J Biol Chem"},{"key":"R52-18-20210208","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1161\/01.HYP.35.1.476","article-title":"Subpressor doses of Ang II increase plasma F2- isoprostanes in rats","volume":"35","author":"Reckelhoff","year":"2000","journal-title":"Hypertension"},{"key":"R53-18-20210208","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1161\/01.HYP.38.3.655","article-title":"Antioxidants block angiotensin II-induced increases in blood pressure and endothelin","volume":"38","author":"Ortiz","year":"2001","journal-title":"Hypertension"},{"key":"R54-18-20210208","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1046\/j.1523-1755.1999.00596.x","article-title":"Free radical-generated F2-isoprostane stimulates cell proliferation and endothelin-1 expression in endothelial cells","volume":"56","author":"Yura","year":"1999","journal-title":"Kidney Int"},{"key":"R55-18-20210208","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/ndt\/gfi314","article-title":"Urinary marker for oxidative stress in kidneys in cisplatin-induced acute renal failure in rats","volume":"21","author":"Zou","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"R56-18-20210208","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S1050-1738(99)00016-X","article-title":"Current status of acrolein as a lipid peroxidation product","volume":"9","author":"Uchida","year":"1999","journal-title":"Trends Cardiovasc Med"},{"key":"R57-18-20210208","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/ndt\/gfm099","article-title":"Overexpression of thioredoxin1 in transgenic mice suppresses development of diabetic nephropathy","volume":"22","author":"Hamada","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"R58-18-20210208","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1159\/000096423","article-title":"An oral adsorbent, AST-120, suppresses oxidative stress in uremic rats","volume":"26","author":"Nakagawa","year":"2006","journal-title":"Am J Nephrol"}],"container-title":["Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00004872-200712000-00018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T00:00:40Z","timestamp":1738972840000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004872-200712000-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":58,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/hjh.0b013e3282efeecb","relation":{},"ISSN":["0263-6352"],"issn-type":[{"type":"print","value":"0263-6352"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}